On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article
Author Archives for Laureline Nourris
DigitalforLife: Digital enterprises, meet health challenges
18 April 2024On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was... View Article
Hemarina, 1er prix du Concours des Technologies Médicales Innovantes
L’entreprise Hemarina, accompagnée par ID2Santé et membre d’Atlanpole Biotherapies, est lauréate du Concours TMI 2015 organisé par l’Alliance pour le... View Article
Hemarina, 1er prix du Concours des Technologies Médicales Innovantes
18 April 2024L’entreprise Hemarina, accompagnée par ID2Santé et membre d’Atlanpole Biotherapies, est lauréate du Concours TMI 2015 organisé par l’Alliance pour le... View Article
AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD
Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that... View Article
AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD
18 April 2024Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that... View Article
Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath
BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced... View Article
Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath
18 April 2024BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced... View Article
Program IHU CESTI: StemHepTher, promising alternatives to liver transplantation
Many types of diseases, whether of genetic origin or not, present a severe dysfunction or generalized dysfunctions of the liver,... View Article
Program IHU CESTI: StemHepTher, promising alternatives to liver transplantation
18 April 2024Many types of diseases, whether of genetic origin or not, present a severe dysfunction or generalized dysfunctions of the liver,... View Article